返回ChemicalBook首页>CAS数据库列表>134865-74-0

134865-74-0

中文名称 4-P-PDOT
英文名称 4-P-PDOT
CAS 134865-74-0
分子式 C19H21NO
分子量 279.38
MOL 文件 134865-74-0.mol
更新日期 2024/06/25 17:16:00
134865-74-0 结构式 134865-74-0 结构式

基本信息

中文别名
N-(4-苯基-1,2,3,4-四氢-2-萘基)丙酰胺
英文别名
AH-024
4-P-PDOT
4-PHENYL-2-PROPIONAMIDOTETRALIN
N-(4-phenyl-1,2,3,4-tetrahydronaphthalen-2-yl)propanamide
N-(4-Phenyl-1,2,3,4-tetrahydronaphthalen-2-yl)propionamide
Propanamide, N-(1,2,3,4-tetrahydro-4-phenyl-2-naphthalenyl)-
4-P-PDOT
4PPDOT
4P-PDOT
AH-024
4-PHENYL-2- PROPIONAMIDOTETRALIN.

物理化学性质

熔点166 °C
沸点480.1±45.0 °C(Predicted)
密度1.11±0.1 g/cm3(Predicted)
储存条件Store at RT
溶解度Soluble in DMSO > 10 mM
酸度系数(pKa)15.87±0.40(Predicted)
形态粉末
颜色白色至米色

安全数据

危险性符号(GHS)GHS hazard pictograms
GHS07
警示词警告
危险性描述H302
RTECS号TX1498350
海关编码2924.29.7790
4-P-PDOT价格(试剂级)
报价日期产品编号产品名称CAS号包装价格
2025/02/08HY-1006094-P-PDOT
4-P-PDOT
134865-74-01mg394元
2025/02/08HY-1006094-P-PDOT
4-P-PDOT
134865-74-05mg900元
2025/02/08HY-1006094-P-PDOT
4-P-PDOT
134865-74-010mM * 1mLin DMSO1211元

常见问题列表

生物活性
4-P-PDOT 是一种有效的,选择性的和亲和性的褪黑激素受体 (MT2) 拮抗剂。4-P-PDOT 对 MT2 的选择性是 MT1 的 300 倍以上。4-P-PDOT 可显着抵消褪黑激素介导的抗氧化作用 (GSH/GSSG比,ERK 磷酸化,Nrf2 核易位,Nrf2 DNA 结合活性)。
靶点

MT2 receptor

体外研究

In CHO-mt1 cells the amidotetraline 4-P-PDOT (10 mM) has no effect on forskolin-stimulated cyclic AMP levels, either alone, or in the presence of Melatonin. In contrast, in CHO-MT2 cells, 4-P-PDOT is an agonist, producing a concentration-dependent inhibition of forskolin stimulated cyclic AMP, with a pEC 50 value of 8.72 and intrinsic activity of 0.86.

Cell Viability Assay

Cell Line: HT-29 and HeLa cells.
Concentration: 30 min.
Incubation Time: 50 µM.
Result: Produced a negligible effect on cell viability induced by melatonin.
体内研究

4-P-PDOT (0.5-1.0 mg/kg; intravenous injection; klotho mutant mice) treatment significantly reverses antioxidant effects mediated by Melatonin. And significantly reverses the changes in the levels of these GSH-related parameters. 4-P-PDOT treatment significantly reverses the memory function of Melatonin-treated klotho mutant mice. 4-P-PDOT also counteracts Melatonin-mediated attenuation in response to the decreases in phospho-ERK expression, Nrf2 nuclear translocation, Nrf2 DNA-binding activity, and GCL mRNA expression in the hippocampi of klotho mutant mice.

Animal Model: Klotho mutant mice treatment with Melatonin
Dosage: 0.5 mg/kg or 1.0 mg/kg
Administration: Intravenous injection
Result: Significantly reversed antioxidant effects mediated by Melatonin. Significantly reversed the changes in the levels of these GSH-related parameters. Significantly reversed the memory function of Melatonin-treated klotho mutant mice.
"134865-74-0" 相关产品信息